CDK6 and glioblastoma: The results demonstrated that the protein levels of CDK4, CDK6, CyclinD1, N-cadherin, and c-Myc were significantly reduced in RANBP10-downregulation GBM cells, whereas p21 and E-cadherin were increased in RANBP10-knockdown groups (Fig. 4A).